SpiroChem
Daniel Kovari is a Researcher Chemist at SpiroChem with a background in synthetic organic chemistry. Previously, Daniel worked at AnalytiCon Discovery where Daniel developed and validated unique 3D-rich spirocyclic scaffolds for library synthesis in drug discovery projects. With a PhD in Medicinal and Pharmaceutical Chemistry from the University of Birmingham, Daniel has a strong foundation in designing and synthesizing compound libraries for various research projects. Through various roles at different companies and educational institutions, Daniel has gained experience in reaction optimization, compound synthesis, and protocol development.
This person is not in any offices
SpiroChem
SpiroChem is an Elite Discovery Chemistry Contract Research Organization (CRO) working with clients worldwide from biotechs, pharmaceutical, agrochemical, and life science companies of all sizes. Our company, operating in Basel, Switzerland, offers unique and innovative solutions covering the entire discovery chemistry value chain: - Proprietary Screening Libraries including high-sp3 fragments, covalent fragments and macrocycles - SpiroKit as turnkey toolboxes for the medicinal chemistry community to speed up research programs - Design & Computational Team for fragment-based drug design (FBDD), structure-based drug design (SBDD) and computational-aided drug design (CADD) - Medicinal Chemistry group including experts in enabling technologies (photochemistry, photoredox, electrochemistry, biocatalysis, …) to access target molecule faster and explore uncharted chemical space - An Early Development division involved in Route Scouting projects to make the bridge between the medicinal chemistry lab and CDMOs - Thanks to two-high potent labs, SpiroChem also supports discovery in the field of ADCs (linker-payload chemistry)